In the current study, we utilized NSCLC cell lines harboring the EGFR L858R/T790M mutation to evaluate the effects and underlying mechanisms of EGCG in overcoming EGFR-TKI resistance. Here, EGFR is linked to non-small cell lung carcinoma.